Form 4: Alan D. Sobel Reports Acquisition of CytoSorbents Corp Shares and Warrants
SEC Form 4
Director Alan D. Sobel reports acquiring shares and warrants of CytoSorbents Corporation through a rights offering.
Summary
- Alan D. Sobel, a director of CytoSorbents Corp, filed a Form 4 detailing changes in beneficial ownership.
- On February 24, 2025, Sobel acquired 21,950 shares of common stock and Series A Right Warrants at a price of $1.13.
- This acquisition was part of a rights offering where Sobel received units consisting of common stock, Series A Warrants, and Series B Warrants for $1.00 per unit.
- The total cost for the 21,950 units was $21,950.
- Sobel directly owns 145,757 shares of Common Stock.
- Sobel also has indirect ownership of 2,000 shares through the Bernard Sobel Revocable Trust.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of insider trading activity. The director's participation in the rights offering could be seen as a slightly positive signal.
Positives
- A director's participation in a rights offering can be seen as a positive signal, indicating confidence in the company's future.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The disclosure provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 2015-04-08 | 55,000 RSUs granted on April 8, 2015 |
| 2016-06-07 | 5,000 RSUs granted on June 7, 2016 |
| 2017-02-24 | 6,000 RSUs granted on February 24, 2017 |
| 2018-03-15 | 3,300 RSUs granted on March 15, 2018 |
| 2025-01-10 | Rights Offering closed on January 10, 2025 |
| 2025-01-17 | Reporting Person exercised certain subscription rights certificates received pursuant to a rights offering on January 17, 2025 |
| 2025-02-24 | Date of transaction: Acquisition of shares and warrants. |
| 2025-02-26 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.